|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 21, 2023 )
The report "Genomics Market by Product & Service (Consumables, Instrument, System & Software), Technology (Sequencing, PCR, Microarray), Study Type (Epigenomics, Biomarker Discovery), Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2028", is projected to reach USD 83.1 billion by 2028 from USD 46.2 billion in 2023, at a CAGR of 12.4% during the forecast period of 2023 to 2028. Factors such as funding provided by government for genomics projects, which is helping support the development and commercialization of new genomics technologies and will create new opportunities for companies operating in the genomics market and rising incidence of cancer and growing application of next generation sequencing for cancer research is driving the genomics market growth. Also, there is significant growth in the number of genomic startup players and funding offered to these start up players which is supporting research and development, driving innovation, increasing competitiveness in the genomics market.
Browse 238 market data Tables and 50 Figures spread through 391 Pages and in-depth TOC on "Genomics Market
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html
The services segment accounted for the second largest share of the product & service segment in the genomics market in 2022.
Based on product and service, the genomics market is segmented into consumables and reagents, services, and instruments, systems, and software. In 2022, the services segment accounted for the largest share of the genomics market. Genomics services generally include data quality assessment, comprehensive analysis, interpreting results, and communicating & presenting results to customers. Many times, outsourced bioinformatics platforms are preferred by researchers and biotechnology companies as they allow them to design and implement their own queries. This allows researchers to focus more on generating results and biostatistics rather than maintaining and managing bioinformatics. Thus, preference to outsource service is promoting market growth.
The biomarker discovery segment accounted for the second largest share of the study type segment in the genomics market in 2022.
Based on study type, the genomics market is segmented into functional genomics, biomarker discovery, pathway analysis, epigenomics, and other study types. Biomarker discovery accounted for the second largest share of the genomics market in 2022. The reason for the large share of this market is genomics technology being rapidly adopted in biomarker discovery for the predicament of individuals at risk of diseases, early detection of diseases, and for advanced diagnostics to understand the prognosis of diseases and to provide personalized disease treatment.
For more Details Speak to Our Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=613
The Europe region is the second fastest-growing region of the genomics market in 2022.
Based on the region, the genomics market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Europe market is estimated to register the second highest growth during the forecast period. The '1+ Million Genomes' Initiative was introduced in Europe in 2018 to gain access to at least 1 million sequenced genomes in the EU. Since Digital Day 2018, 24 EU countries, the UK, and Norway, have signed member state declarations on inducing efforts toward creating a European data infrastructure for genomic data and implementing the common nation rule to enable federated data access. Such one-of-a-kind initiatives by European countries are expected to propel the growth of the genomics market in this region.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=613
Key players in the genomics Market include Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (US), PerkinElmer Inc. (US), F. Hoffmann-La Roche, Ltd. (Switzerland),
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
